Credit Suisse Ag Pa Vmed Inc. Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.1 - $9.39 $313,226 - $576,705	-61,417 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $190,046 - $331,017	48,113 Added 361.64%	61,417 $393,000
Q1 2021 May 14, 2021	BUY	$2.01 - $5.55 $5,330 - $14,718	2,652 Added 24.9%	13,304 $59,000
Q4 2020 Feb 12, 2021	BUY	$1.73 - $2.13 $18,427 - $22,688	10,652 New	10,652 $23,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $64.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.